Back HCV Populations Prisoners

Early Antiretroviral Treatment Reduces New HIV Infections, Says British Columbia Study

A study published in the July 18, 2010 advance online edition of the Lancet (free full text with registration) and discussed at the XVIII International AIDS Conference (AIDS 2010) this week in Vienna offers further evidence that widespread early antiretroviral therapy (ART) can reduce the spread of HIV at a population level. Universal early ART is not without controversy, however, due to concerns about side effects, drug resistance, and resource allocation.

Read more:

Some Prisoners Can Achieve Good Hepatitis C Treatment Outcomes, but Response Rates May be Lower than those of Non-inmates

Some prisoners with chronic hepatitis C virus (HCV) infection -- especially genotypes 2 or 3 -- can achieve sustained response using pegylated interferon plus ribavirin, but the likelihood of responding is lower than it is for patients in the outside community, according to a study in the August 2009 Journal of Clinical Gastroenterology.

Read more: